321 related articles for article (PubMed ID: 20500811)
1. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
[TBL] [Abstract][Full Text] [Related]
2. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study: comparative effects of lung volume therapy between slow and fast deep-breathing techniques on pulmonary function, respiratory muscle strength, oxidative stress, cytokines, 6-minute walking distance, and quality of life in persons with COPD.
Leelarungrayub J; Puntumetakul R; Sriboonreung T; Pothasak Y; Klaphajone J
Int J Chron Obstruct Pulmon Dis; 2018; 13():3909-3921. PubMed ID: 30584292
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.
Attaran D; Lari SM; Towhidi M; Marallu HG; Ayatollahi H; Khajehdaluee M; Ghanei M; Basiri R
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():335-40. PubMed ID: 21037957
[TBL] [Abstract][Full Text] [Related]
5. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD.
Al-shair K; Kolsum U; Dockry R; Morris J; Singh D; Vestbo J
Respir Res; 2011 Jan; 12(1):3. PubMed ID: 21208443
[TBL] [Abstract][Full Text] [Related]
7. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
8. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
9. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
11. The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.
Baldi S; Jose PE; Bruschi C; Pinna GD; Maestri R; Rezzani A; Bellinzona E; Fracchia C; Dacosto E; Crotti P; Montemartini S
Int J Chron Obstruct Pulmon Dis; 2014; 9():1091-9. PubMed ID: 25336940
[TBL] [Abstract][Full Text] [Related]
12. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
[TBL] [Abstract][Full Text] [Related]
15. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
Zeng YY; Hu WP; Zuo YH; Wang XR; Zhang J
Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663
[TBL] [Abstract][Full Text] [Related]
16. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia correlates with systemic inflammation in COPD.
Byun MK; Cho EN; Chang J; Ahn CM; Kim HJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():669-675. PubMed ID: 28255238
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.
Izquierdo JL; Martínez A; Guzmán E; de Lucas P; Rodríguez JM
Int J Chron Obstruct Pulmon Dis; 2010 Nov; 5():387-94. PubMed ID: 21103405
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
20. A gender difference in circulating neutrophils in malnourished patients with COPD.
Larsson S; Nordenson A; Glader P; Yoshihara S; Lindén A; Slinde F
Int J Chron Obstruct Pulmon Dis; 2011; 6():83-8. PubMed ID: 21407820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
